Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Anaptysbio (ANAB) Accumulated Depreciation & Amortization (2016 - 2026)

Anaptysbio filings provide 11 years of Accumulated Depreciation & Amortization readings, the most recent being $7.3 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 4878.77% to $7.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.3 million, a 4878.77% increase, with the full-year FY2025 number at $7.1 million, up 1078.05% from a year prior.
  • Accumulated Depreciation & Amortization hit $7.3 million in Q1 2026 for Anaptysbio, up from $7.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $7.3 million in Q1 2026 to a low of $146000.0 in Q1 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $428000.0 (2025), compared with a mean of $1.2 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: decreased 10.43% in 2025 and later soared 4878.77% in 2026.
  • Anaptysbio's Accumulated Depreciation & Amortization stood at $675000.0 in 2022, then dropped by 3.41% to $652000.0 in 2023, then decreased by 7.06% to $606000.0 in 2024, then skyrocketed by 1078.05% to $7.1 million in 2025, then increased by 1.82% to $7.3 million in 2026.
  • The last three reported values for Accumulated Depreciation & Amortization were $7.3 million (Q1 2026), $7.1 million (Q4 2025), and $428000.0 (Q3 2025) per Business Quant data.